<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00519454</url>
  </required_header>
  <id_info>
    <org_study_id>05-024</org_study_id>
    <nct_id>NCT00519454</nct_id>
  </id_info>
  <brief_title>Estrogen and Gender Biased Autoimmunity</brief_title>
  <official_title>Estrogen and Gender Biased Autoimmunity in Systemic Lupus Erythematosus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Center for Rheumatic Disease, Allergy, &amp; Immunology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>The Center for Rheumatic Disease, Allergy, &amp; Immunology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study involves research to investigate how estrogen affects women of childbearing age&#xD;
      and its correlation to Systemic Lupus Erythematosus. The findings from this study might help&#xD;
      determine how body cells, called T Cells, react to estrogen. The study will seek to determine&#xD;
      if cells from women with Lupus, react differently from cells in persons without Lupus. We&#xD;
      will attempt to identify genetic factors that determine the effects of estrogen on Lupus&#xD;
      cells.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a 3-year study. The total number of subjects enrolled will depend on the results&#xD;
      obtained. The subjects will be at least 18 years of age and pre-menopausal. Exclusion to&#xD;
      include pregnant women, and all subjects are told not to get pregnant while on study. Also,&#xD;
      they cannot take hormones by mouth or patch while on study. The study can include healthy&#xD;
      subjects as well. Blood will be drawn (120 ml) four times a year, randomly.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2005</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Systemic Lupus Erythematosus</condition>
  <arm_group>
    <arm_group_label>Female Lupus patients</arm_group_label>
    <description>Females who are still childbearing age, not on hormones, with Systemic Lupus Erythematosus, still cycling.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Peripheral lab draws</intervention_name>
    <description>100ml blood for analysis, taken no more than 4 times in one year.</description>
    <arm_group_label>Female Lupus patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Female subjects with SLE and still cycling, not on hormones, compared to normal controls,&#xD;
        female subjects still cycling, also not on hormones and not diagnosed with SLE.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  female subjects with Lupus, and female subjects without Lupus. age at least 18, not&#xD;
             pregnant and not planning to get pregnant.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or planning to get pregnant. On hormone replacement, or birth control of any&#xD;
             kind.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nabih I Abdou, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Center for Rheumatic Disease, Allergy and Immunology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nabih I Abdou, MD, PhD.</last_name>
    <phone>816-531-0930</phone>
    <email>niabdou@centerforrheumatic.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cindy Greenwell, RN</last_name>
    <phone>816-531-0930</phone>
    <email>cindy@centerforrheumatic.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Center for Rheumatic Disease, Allergy and Immunology</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nabih I Abdou, MD, PhD</last_name>
      <phone>816-531-0930</phone>
      <email>niabdou@centerforrheumatic.com</email>
    </contact>
    <contact_backup>
      <last_name>Cindy A Greenwell, RN</last_name>
      <phone>816-531-0930</phone>
      <email>cindy@centerforrheumatic.com</email>
    </contact_backup>
    <investigator>
      <last_name>Nabih I Abdou, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <study_first_submitted>August 20, 2007</study_first_submitted>
  <study_first_submitted_qc>August 21, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2007</study_first_posted>
  <last_update_submitted>September 3, 2010</last_update_submitted>
  <last_update_submitted_qc>September 3, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 8, 2010</last_update_posted>
  <responsible_party>
    <name_title>Nabih I Abdou</name_title>
    <organization>Center for Rheumatic Disease Allergy &amp; Immunology</organization>
  </responsible_party>
  <keyword>Systemic Lupus Erythematosus</keyword>
  <keyword>Estrogen receptors</keyword>
  <keyword>T cells</keyword>
  <keyword>Hormones</keyword>
  <keyword>Female adult SLE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
    <mesh_term>Autoimmune Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

